本文已被:浏览 143次 下载 173次
投稿时间:2026-04-07 网络发布日期:2026-10-23
投稿时间:2026-04-07 网络发布日期:2026-10-23
中文摘要: 目的 比较经导管动脉化疗栓塞术(TACE)联合手术切除和单纯手术切除在肝细胞癌(HCC)破裂出血患者中的疗效和生存情况,探讨二者对肝功能指标、肿瘤标志物和患者生存质量的影响。方法 采用回顾性分析方法,选择2021 年5 月至2023 年5 月山东第一医科大学附属菏泽医院收入的原发性HCC 破裂出血120 例患者作为研究对象,按照治疗方式不同分为切除组(n=60)和联合栓塞组(n=60)。切除组采用第一肝门阻断法进行手术切除治疗,联合栓塞组在此基础上联合TACE 进行治疗,比较两组患者的肝功能指标、血清肿瘤标志物、生存质量水平、预后情况。结果 治疗后联合栓塞组和切除组的丙氨酸氨基转移酶、天冬氨酸氨基转移酶和总胆红素水平比较差异无统计学意义(P>0.05)。治疗后联合栓塞组甲胎蛋白、糖类抗原19-9(CA19-9)、磷脂酰肌醇蛋白聚糖3(GPC3)水平低于切除组(P<0.05)。两组治疗后肝癌患者生命质量测定量表(QOL-LC)评分均升高,且联合栓塞组量表评分明显更高(P<0.05)。联合栓塞组1 年累积生存率为91.67%,明显高于切除组的71.67%(log-rank χ2=8.624,P=0.003)。联合栓塞组的1年累积无进展生存率亦高于切除组(83.33% vs 63.33%,log-rank χ2=7.752,P=0.005)。结论 TACE联合手术切除能够有效降低原发性HCC破裂出血患者血清肿瘤标志物水平,提高患者的生存质量,优化患者预后状态且不增加肝功能损伤。
Abstract:Objective To compare the efficacy and survival outcomes of transcatheter arterial chemoembolization(TACE)combined with surgical resection versus surgical resection alone in patients with ruptured hepatocellular carcinoma(HCC),and to investigate their effects on liver function indicators,tumor markers,and quality of life.Methods A total of 120 patients with ruptured HCC admitted to Heze Hospital Affiliated to Shandong First Medical University from May 2021 to May 2023 were retrospectively selected. They were divided into a resection group(n=60)and a combined embolization group(n=60)according to treatment modality. The resection group underwent surgical resection using the Pringle maneuver(hepatic inflow occlusion),while the combined embolization group received TACE in addition to surgical resection. Liver function indicators,serum tumor markers,quality-of-life scores,and prognosis were compared between the two groups. Results After treatment,there were no statistically significant differences in alanine aminotransferase,aspartate aminotransferase,and total bilirubin levels between the two groups(P>0.05). The levels of alpha-fetoprotein,carbohydrate antigen 19-9,and glypican-3 in the combined embolization group were significantly lower than those in the resection group(P<0.05). The Quality of Life-Liver Cancer(QOL-LC)scores increased significantly in both groups after treatment,with the combined embolization group showing significantly higher scores than the resection group(P<0.05). The 1 - year cumulative survival rate was 91.67% in the combined embolization group,which was significantly higher than that(71.67%)in the resection group(log-rank χ2=8.624,P=0.003). The 1-year cumulative progression-free survival rate was also significantly higher in the combined embolization group compared with the resection group(83.33% vs 63.33%,log-rank χ2=7.752,P=0.005). Conclusion TACE combined with surgical resection for patients with ruptured primary HCC can effectively reduce serum tumor marker levels,improve both quality of life and prognosis,and does not aggravate liver function impairment.
keywords: Hepatocellular carcinoma Spontaneous rupture bleeding Resection Transcatheter arterial chemoem-bolization Tumor markers Quality of life Liver function Interventional therapy
文章编号: 中图分类号:R735.7 文献标志码:A
基金项目:
附件
引用文本:
牛德方,郑旭,季芳.经导管动脉化疗栓塞术联合手术切除治疗肝细胞癌破裂出血的临床疗效[J].中国临床研究,2026,39(10):1579-1583,1589.
牛德方,郑旭,季芳.经导管动脉化疗栓塞术联合手术切除治疗肝细胞癌破裂出血的临床疗效[J].中国临床研究,2026,39(10):1579-1583,1589.
